The 2015 text of EU GMP Annex 15 (section 10) says the protocol should specify the sampling locations and the rationale for selecting them. Choose swab points where cleaning is most likely to fail: valve seats, gaskets, dead ends and accumulation points, on every product-contact material, each with a defined area and a recovery study.
WHO Technical Report Series 1044, Annex 4, says a technology transfer project may be divided into four phases: initiation, planning, transfer execution, and review and close-out. A project that begins with the first trial batch has skipped the gap analysis, the transfer protocol and the knowledge package, and cannot explain a failed batch.
Five times the batch at the same set-points gives different granules, because some parameters depend on scale. WHO's technology transfer guideline says batch sizes should be compared and the impact assessed where they differ. Compare the equipment, check dust, exhaust and water at the new scale, and settle set-points with trial batches.
The 2015 text of EU GMP Annex 15 allows a worst-case product approach to cleaning validation if a scientific rationale is provided; criteria may include solubility, cleanability, toxicity and potency. Put them in a table per product, with the PDE and the residue load, and reopen it when a new product arrives.
A stored value of 22.4 means nothing without its sensor tag, unit, time stamp, status flag, author and audit trail. The MHRA's 2018 data integrity guidance defines metadata as data that describe the attributes of other data and provide context and meaning. Test that backups, exports and migrations carry them.
Cleanroom testing is often bought late and on price, and QA first meets the tester as a signature on a report. Before the order, hold evidence of tester training, calibrated instruments, method statements to ISO 14644-1 and ISO 14644-3, a sample report and agreed raw data practice, then list the tester as an approved supplier.
EU GMP Annex 15 (2015) says a formal release for the next qualification stage should be authorised, and that conditional approval to proceed can be given where there is a documented assessment of no significant impact on the next activity. That assessment is made item by item, against the tests that follow.
EU GMP Annex 15 (2015) accepts concurrent validation in exceptional circumstances, where there is a strong benefit-risk ratio for the patient. The decision must be justified, documented in the validation master plan and approved by authorised personnel. A project that is running late does not meet that test.
Each SKU left on a transfer list has to be covered by validation and stability work. Before the transfer, list the SKUs with volume and market, group them by formulation, process and pack line, retire or merge the tail, choose the extremes where bracketing is justified, and order the work by value and risk.
A protocol line that says 'as per design' leaves the tester to choose the document and the tolerance on test day. EU GMP Annex 15 (2015) says protocols should define the acceptance criteria. Write a number with its unit and tolerance, the method and room state, and the source document with its revision.
Analytical method transfer is the documented process that qualifies a receiving laboratory to use a procedure that originated elsewhere. Routes include comparative testing, co-validation, revalidation and a justified waiver. The WHO guideline on technology transfer says procedures should be implemented before process validation samples are tested, with acceptance criteria agreed before the protocol is executed.
The product quality review is the regular, documented review of each authorised medicinal product, normally annual in the 2013 text of EU GMP Chapter 1; the US rule is 21 CFR 211.180(e). One listed item is the qualification status of equipment and utilities such as HVAC and water, which engineering should keep current through the year.